Study Reveals New Insights Into Predictors of Mortality in Patients With VEXAS Syndrome
Researchers aimed to provide deeper insight into the predictors of mortality and survival in patients with VEXAS syndrome.
Researchers aimed to provide deeper insight into the predictors of mortality and survival in patients with VEXAS syndrome.
Researchers evaluated the pharmacologic response of rituximab dosing for maintenance therapy in patients with ANCA-associated vasculitis.
Using data from the French National TMA registry, study authors evaluated the demographic and clinical characteristics of thrombotic microangiopathy in autoimmune diseases, and assessed therapeutic approaches.